This project will evaluate the feasibility and reproducibility of novel WB-MRI for the characterization of pre-malignant lesions in NF-1 patients.
The one-year grant of $50,000 supports a postdoctoral or clinical research fellow conducting translational or clinical sarcoma research.
Real-world data showed ide-cel was active in patients with central nervous system manifestations of multiple myeloma.
Neil Iyengar, MD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the impact of lifestyle interventions and retrospective analyses on various outcomes in…
This study examines a modified progressive disease classification and its association with postprogression survival in patients treated with atezolizumab across various solid tumors.
Taletrectinib demonstrated favorable efficacy and tolerability data in the TRUST-I and TRUST-II trials for the treatment of patients with advanced non–small cell lung cancer.
NCCR collects data and publishes statistics to better understand the causes, outcomes, effective treatments, and later effects of cancer among children, adolescents, and young adults…
Almost every patient with a cancer diagnosis has asked me, “How should I change my diet?” Yesterday’s Plenary Scientific Session, Ketogenic Diet Enhances CAR-T Cell…
Dr. David Barbie and his team will receive a 4-year, $2.5 million grant to support their research on immune-based approaches to target drug-resistant cancer cells.
During a Case-Based Roundtable® event, Komal Jhaveri, MD, FACP, discussed dosing and toxicity concerns with the approved CDK4/6 inhibitor regimens used in the adjuvant setting for…
